FinQuota.com
Home
News
Screener
Backtests
Tools
Compare Stocks
Dividend Calculator
Options Calculator
NYSE Holidays
NASDAQ Holidays
Earnings Calendar
Widgets
Filter
Dividend Stocks
US Dividend Stocks
Monthly Dividend Stocks
Annual Dividend Stocks
Quarterly Dividend Stocks
Semi-Annual Dividend Stocks
Best Penny Stocks
Undervalued Stocks
New Stocks
Uptrend Stocks
Uptrend Penny Stocks
Blue Chip
Blue Chip Stocks With High Dividends
Blue Chip Under $10
Blue Chip Under $20
Blue Chip Under $50
Undervalued Blue Chip Stocks
By Cap
Best Small Cap
Best Micro Cap
Best Mid Cap
Best Large Cap
By Sector
Oil Stocks
Energy Stocks
Technology Stocks
AI Stocks
Pharma Stocks
Financial Stocks
By Price
Under $200
Under $100
Under $50
Under $20
Under $10
Under $5
Under $1
By 52 Week Range
Best 52 Week Low
Best 52 Week Nasdaq Low
Best 52 Week NYSE Low
Best 52 Week Low Penny
Best 52 Week Low Blue Chip
Best 52 Week High
Best 52 Week Nasdaq High
Best 52 Week NYSE High
Best 52 Week High Penny
By Exchange
Best Nasdaq Stocks
Best NYSE Stocks
By Insider Activity
Insider Buying
Insider Selling
By Indicator
MACD Crossed Above Signal Line
MACD Crossed Above Zero
RSI Above 90
RSI Above 80
RSI Above 70
RSI Above 50
RSI Below 50
RSI Below 30
RSI Below 20
RSI Below 10
By P/E Ratio
Tech Stocks with Low PE
PE Ratio Less Than 1
PE Ratio Less Than 10
PE Ratio Less Than 15
US stocks With Low PE
Low PE & High Dividends
Low PE & High EPS
Large Cap & Lowest PE
Learning
Books
Trading Platforms
Forum
Auto (Default)
Light mode
Dark
Sign In
Sign Up
FinQuota.com
Home
Account
Sign In
Sign Up
News
Screener
Backtests
Tools
Compare Stocks
Dividend Calculator
Options Calculator
NYSE Holidays
NASDAQ Holidays
Earnings Calendar
Widgets
Filter
Dividend Stocks
US Dividend Stocks
Monthly Dividend Stocks
Annual Dividend Stocks
Quarterly Dividend Stocks
Semi-Annual Dividend Stocks
Best Penny Stocks
Undervalued Stocks
New Stocks
Uptrend Stocks
Uptrend Penny Stocks
Blue Chip
Blue Chip Stocks With High Dividends
Blue Chip Under $10
Blue Chip Under $20
Blue Chip Under $50
Undervalued Blue Chip Stocks
By Cap
Best Small Cap
Best Micro Cap
Best Mid Cap
Best Large Cap
By Sector
Oil Stocks
Energy Stocks
Technology Stocks
AI Stocks
Pharma Stocks
Financial Stocks
By Price
Under $200
Under $100
Under $50
Under $20
Under $10
Under $5
Under $1
By 52 Week Range
Best 52 Week Low
Best 52 Week Nasdaq Low
Best 52 Week NYSE Low
Best 52 Week Low Penny
Best 52 Week Low Blue Chip
UBest 52 Week High
Best 52 Week Nasdaq High
Best 52 Week NYSE High
Best 52 Week High Penny
By Exchange
Nasdaq Stocks
NYSE Stocks
By Insider Activity
Insider Buying
Insider Selling
By Indicator
MACD Crossed Above Signal Line
MACD Crossed Above Zero
RSI Above 90
RSI Above 80
RSI Above 70
RSI Above 50
RSI Below 50
RSI Below 30
RSI Below 20
RSI Below 10
By P/E Ratio
Tech Stocks with Low PE
PE Ratio Less Than 1
PE Ratio Less Than 10
PE Ratio Less Than 15
US stocks With Low PE
Low PE & High Dividends
Low PE & High EPS
Large Cap & Lowest PE
Learning
Books
Trading Platforms
Forum
Search Ticker
Home
RAPP
RAPP News
Latest Rapport Therapeutics Inc. Common Stock (RAPP) News on September 16, 2024
RAPP
GlobeNewswire
11 days ago
Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences
RAPP
GlobeNewswire
18 days ago
Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen’s 4th Annual Novel Mechanisms in Neuropsychiatry Summit
RAPP
GlobeNewswire
a month ago
Rapport Therapeutics Reports Second Quarter Financials and Provides Business Update
RAPP
GlobeNewswire
2 months ago
Rapport Therapeutics to Present Data for TARPγ8 AMPAR Negative Modulator at IASP 2024 World Congress on Pain
RAPP
GlobeNewswire
3 months ago
Rapport Therapeutics Announces Closing of $174 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement
Share on Social Networks: